Application of Herpesvirus Saimiri as an Alternative Gene Therapy Vector

Volume: 25 Number: 1 March 31, 2016
Tuna Toptan
EN TR

Application of Herpesvirus Saimiri as an Alternative Gene Therapy Vector

Abstract

Herpesvirus saimiri is the prototype rhadinovirus and is closely related to human Kaposi’s sarcoma-associated herpesvirus. Herpesvirus saimiri strains of subgroup C transduce a broad spectrum of cancer cells and primary cells including human T lymphocytes very efficiently and enable stable transgene expression. Herpesvirus saimiri as a gene therapy vector is favorable because of its large packaging capacity, extensive cell tropism, and long-termed persistence as non-integrating episomes and thus exhibits numerous advantages over commonly used viral vectors. In order to use Herpesvirus saimiri as a secure and versatile gene therapy vehicle, it should be easily manipulated and modified. The recent advances in molecular cloning of large genomic fragments such as virus genomes as bacterial artificial chromosomes facilitated the functional studies and manipulation of herpesviruses using the recombination system of bacteria. Among these, red-recombination based “en passant” mutagenesis method enables seamless genome modification such as deletion, insertion and point mutation very easily and efficiently.

Keywords

-

References

  1. Davison AJ. Overview of Classification. In Human Herpesviruses (Eds A Arvin, G Campadelli-Fiume, E Mocarski, PS Moore, B Roizman, R Whitley, K Yamanishi):3-9. Cambridge University Press, 2007.
  2. Longnecker R, Neipel F. Introduction of the human gammaherpesviruses. In Human Herpesviruses (Eds A Arvin, G Campadelli-Fiume, E Mocarski, PS Moore, B Roizman, R Whitley, K Yamanishi):341-59. Cambridge University Press, 2007.
  3. Kieff ED, Rickenson A. Epstein-Barr virus and its replication. In: Fields Virology, 5th ed (Eds BN Fileds, DM Knipe, PM Howley):2603-54. Lippincott Williams and Wilkins, Philadelphia, 2007.
  4. Fickenscher H, Fleckenstein B. Herpesvirus saimiri. Philos Trans R Soc Lond B Biol Sci. 2001;356:545-67.
  5. Fleckenstein B, Ensser A. Gammaherpesviruses of New World primates. In Human Herpesviruses (Eds A Arvin, G Campadelli-Fiume, E Mocarski, PS Moore, B Roizman, R Whitley, K Yamanishi):1076-92. Cambridge University Press, 2007.
  6. Melendez LV, Hunt RD, Daniel MD, Garcia FG, Fraser CE. Herpesvirus saimiri. Experimentally induced malignant lymphoma in primates. Lab Anim Care. 1969;19:378-86.
  7. Wright J, Falk LA, Collins D, Deinhardt F. Mononuclear cell fraction carrying herpesvirus saimiri in persistently infected squirrel monkeys. J Natl Cancer Inst. 1976;57:959-62.
  8. Ensser A, Fleckenstein B. T-cell transformation and oncogenesis by gamma2-herpesviruses. Adv Cancer Res. 2005;93:91-128.
  9. Ensser A, Thurau M, Wittmann S, Fickenscher H. The genome of herpes-virus saimiri C488 which is capable of transforming human T cells. Virology. 2003;314: 471-87.
  10. Desrosiers RC, Falk LA. Herpesvirus saimiri strain variability. J Virol. 1982;43:352-6.
AMA
1.Toptan T. Application of Herpesvirus Saimiri as an Alternative Gene Therapy Vector. Arşiv Kaynak Tarama Dergisi. 2016;25(1):41-51. doi:10.17827/aktd.71668